Table 5.
The cytokines concentration in breast cancer patients on adjuvant chemotherapy at the start and the end of the study.
| Parameters | Intervention group-start (N = 14) | Intervention group-the end (N = 14) | Placebo group- start (N = 15) | Placebo group- the end (N = 15) | p | ||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Range | Median | Range | Median | Range | Median | Range | ||
| IL-10 pg/ml | 7.26 | 6.71–10.95 | 7.07 | 6.02–10.54 | 7.26 | 6.44–9.72 | 7.15 | 6.71–15.47 | |
| IL-6 ng/ml | 30.67 | 0.11–116.42 | 9.42*** | 0.95–44.23 | 33.79 | 0.95–70.08 | 12.76*** | 0.90–40.12 | 0.000 |
| IL-8 pg/ml | 10.94 | 9.21–16.21 | 10.86 | 7.08–34.31 | 11.86 | 9.45–19.66 | 11.03 | 9.31–18.45 | |
| TNF-alpha ng/ml | 166.90 | 69.30–307.88 | 152.01 | 74.52–198.12 | 155.04 | 86.70–204.37 | 142.65 | 98.14–131.91 | |
The most abundant fatty acids in oils are in bold.
Results are presented as median, upper and lower quartile with minimal and maximal values. ***p < 0.001 indicates a statistically significant difference from the baseline for the same group. p values represent statistically different between intervention and placebo groups after treatment.
IL, Interleukin; TNF, tumor necrosis factor.